Research and Development

The destructive forces of Hurricane Maria have caused untold damage to the island nation, with a reported 13 people left …

Axovant Sciences was set up with just one drug candidate in its portfolio, and a risky one, at that. The …

Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …

Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …

New research conducted by the Mayo Clinic in Minnesota has found participant groups for clinical trials in cancer underrepresent ethnic …

The October edition of Pharmafocus is now live! You can read it here.

The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …

It was only last year that Allergan decided to cough up $1.7 billion to acquire Tobira Therapeutics, with the main …

Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …

It’s been a great week for drug research and access, with the first-ever FDA approval of a biosimilar in cancer …

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …

Researchers at the Boston Medical Center are investigating the potential of utilising weight loss drugs in the treatment of cocaine …

Novartis has announced that its targeted therapy Rydapt (midostaurin) has received EU approval in the two rare cancer indications: newly …

It has been announced that the Bill & Melina Gates Foundation will invest up to $40 million in UK-based Immunocore …

The World Health Organization (WHO) has released a report indicating that worldwide development of new antibiotics is not keeping pace …